ViroPharma Cash from Investing Quarterly:
8.643M for March 31, 2013ViroPharma Historical Cash from Investing Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 8.643M |
| Dec. 31, 2012 | 25.29M |
| Sept. 30, 2012 | -75.45M |
| June 30, 2012 | -5.784M |
| March 31, 2012 | 17.89M |
| Dec. 31, 2011 | -48.83M |
| Sept. 30, 2011 | 7.35M |
| June 30, 2011 | -32.32M |
| March 31, 2011 | -27.24M |
| Dec. 31, 2010 | -14.94M |
| Sept. 30, 2010 | -15.17M |
| June 30, 2010 | -54.13M |
| March 31, 2010 | -17.69M |
| Dec. 31, 2009 | -0.621M |
| Sept. 30, 2009 | -4.263M |
| June 30, 2009 | -3.288M |
| March 31, 2009 | -0.757M |
| Dec. 31, 2008 | -325.42M |
| Sept. 30, 2008 | 74.56M |
| June 30, 2008 | 136.26M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Cash From Investing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More
VPHM Cash from Investing Quarterly Benchmarks
| Companies | |
|---|---|
| Optimer Pharmaceuticals | 65.82M |
| Halozyme Therapeutics | -0.5394M |
| Incyte | -0.758M |
VPHM Cash from Investing Quarterly Rankings
| Overall |
95th percentile 364 of 8008 |
| Sector |
94th percentile 38 of 685 in Healthcare |
| Industry |
91st percentile 22 of 249 in Biotechnology |
VPHM Cash from Investing Quarterly Range, Past 5 Years
| Minimum | -325.42M | Dec 2008 |
| Maximum | 136.25M | Jun 2008 |
| Average | -17.80M |
